DK0825256T3 - Hybridcelle og dens anvendelse til fremstilling af et lægemiddel til inducering af en tumorimmunitet - Google Patents

Hybridcelle og dens anvendelse til fremstilling af et lægemiddel til inducering af en tumorimmunitet

Info

Publication number
DK0825256T3
DK0825256T3 DK97113697T DK97113697T DK0825256T3 DK 0825256 T3 DK0825256 T3 DK 0825256T3 DK 97113697 T DK97113697 T DK 97113697T DK 97113697 T DK97113697 T DK 97113697T DK 0825256 T3 DK0825256 T3 DK 0825256T3
Authority
DK
Denmark
Prior art keywords
inducing
drug
manufacture
hybrid cell
tumor immunity
Prior art date
Application number
DK97113697T
Other languages
English (en)
Inventor
Ralf Mocikat
Horst Lindhofer
Stefan Thierfelder
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Application granted granted Critical
Publication of DK0825256T3 publication Critical patent/DK0825256T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
DK97113697T 1996-08-23 1997-08-07 Hybridcelle og dens anvendelse til fremstilling af et lægemiddel til inducering af en tumorimmunitet DK0825256T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19634159A DE19634159C1 (de) 1996-08-23 1996-08-23 Induktion einer Tumorimmunität durch Injektion von Hybridzellen

Publications (1)

Publication Number Publication Date
DK0825256T3 true DK0825256T3 (da) 2003-10-20

Family

ID=7803543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97113697T DK0825256T3 (da) 1996-08-23 1997-08-07 Hybridcelle og dens anvendelse til fremstilling af et lægemiddel til inducering af en tumorimmunitet

Country Status (8)

Country Link
US (1) US6007807A (da)
EP (1) EP0825256B1 (da)
JP (1) JP3676915B2 (da)
AT (1) ATE243742T1 (da)
DE (2) DE19634159C1 (da)
DK (1) DK0825256T3 (da)
ES (1) ES2201228T3 (da)
PT (1) PT825256E (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19634159C1 (de) * 1996-08-23 1997-09-25 Gsf Forschungszentrum Umwelt Induktion einer Tumorimmunität durch Injektion von Hybridzellen
US6682928B2 (en) * 1997-12-02 2004-01-27 Medarex, Inc. Cells expressing anti-Fc receptor binding components
DE19835633C1 (de) * 1998-08-06 1999-08-26 Gsf Forschungszentrum Umwelt Induktion einer Tumorimmunität durch Redirektion von Tumorzellen gegen Antigen-präsentierende Zellen
PL1874821T3 (pl) 2005-04-26 2013-09-30 Trion Pharma Gmbh Kombinacja przeciwciał i glikokortykoidów do leczenia raka
GB0512225D0 (en) * 2005-06-16 2005-07-27 Univ Sheffield Immunoglobulin molecules

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1214123A (en) * 1983-01-20 1986-11-18 Masashi Matsui Cell lines for use in the preparation of hybridoma cells
WO1992008802A1 (en) * 1990-10-29 1992-05-29 Cetus Oncology Corporation Bispecific antibodies, method of production, and uses thereof
US6129914A (en) * 1992-03-27 2000-10-10 Protein Design Labs, Inc. Bispecific antibody effective to treat B-cell lymphoma and cell line
ES2143553T3 (es) * 1993-09-02 2000-05-16 Dartmouth College Anticuerpos anti-gp39 y sus utilizaciones.
DE4337197C1 (de) * 1993-10-30 1994-08-25 Biotest Pharma Gmbh Verfahren zur selektiven Herstellung von Hybridomazellinien, die monoklonale Antikörper mit hoher Zytotoxizität gegen humanes CD16-Antigen produzieren, sowie Herstellung bispezifischer monoklonaler Antikörper unter Verwendung derartiger monoklonaler Antikörper und des CD30-HRS-3-Antikörpers zur Therapie menschlicher Tumore
WO1995016775A1 (en) * 1993-12-14 1995-06-22 Yajun Guo Tumor cell fusions and methods for use of such tumor cell fusions
DE122009000068I2 (de) * 1994-06-03 2011-06-16 Ascenion Gmbh Verfahren zur Herstellung von heterologen bispezifischen Antikörpern
DE19634159C1 (de) * 1996-08-23 1997-09-25 Gsf Forschungszentrum Umwelt Induktion einer Tumorimmunität durch Injektion von Hybridzellen
DE19835633C1 (de) * 1998-08-06 1999-08-26 Gsf Forschungszentrum Umwelt Induktion einer Tumorimmunität durch Redirektion von Tumorzellen gegen Antigen-präsentierende Zellen

Also Published As

Publication number Publication date
US6007807A (en) 1999-12-28
EP0825256A3 (de) 2001-04-04
PT825256E (pt) 2003-11-28
DE19634159C1 (de) 1997-09-25
JPH10155483A (ja) 1998-06-16
ES2201228T3 (es) 2004-03-16
ATE243742T1 (de) 2003-07-15
DE59710330D1 (de) 2003-07-31
EP0825256A2 (de) 1998-02-25
EP0825256B1 (de) 2003-06-25
JP3676915B2 (ja) 2005-07-27

Similar Documents

Publication Publication Date Title
WO1999004265A8 (en) Cancer associated nucleic acids and polypeptides
PL331091A1 (en) Therapeutic multispecific compounds encompassing antibodies against the fcalpha receptor
TR200001253T2 (tr) Tümöre özel antijenler
DK318481A (da) Syntetisk peptid specifik antigenisk determinant og fremgangsmaade til fremstilling af antigene meneraler deraf
DK0826696T3 (da) Anvendelse af bi- og trispecifikke antistoffer til inducering af en tumorimmunitet
ATE306939T1 (de) Mehrstufiger kaskade-erhöhungsimpfstoff
PT800578E (pt) Sequencias do anticorpo 3h1 anti-idiotipico monoclonal recombinante associado ao antigenio carcioembrionario humano
DE69224496D1 (de) Humaner monoklonaler Antikörper, spezifisch gegen ein Oberflächenantigen der Krebszell-Membran
DE3484520D1 (de) Monoklonale antikoerper gegen menschlichen dickdarmkrebs und verfahren.
DK0616613T3 (da) Fragmenter af prionprotein
AR005339A1 (es) Anticuerpos monoclonales antiidiotipos (ab2) y sus usos
DK0910407T3 (da) Fremgangsmåde og sammensætning til rekonformation af multiepitope antigener for at initiere et immunrespons
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE3173342D1 (en) Agent for tumor localization and therapy with labeled antibodies and antibody fragments
DE69522689D1 (de) Zellzyklus-unabhängige, gliomaoberflach-spezifische, menschliche monoklonale antikörper
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DK0825256T3 (da) Hybridcelle og dens anvendelse til fremstilling af et lægemiddel til inducering af en tumorimmunitet
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
DK0840620T3 (da) IL-8-antagonister til behandling af astma
DE3485712D1 (de) Monoklonale antikoerper gegen menschliche nierenkrebsantigene und verfahren.
ES2180052T3 (es) Anticuerpos especificos del cancer de prostata para inmunodeteccion e inmunoterapia.
DE3580482D1 (de) Monoklonale antikoerper und immunisierung damit.
EP0585364A4 (en) THE ANTIQUE CTAA 81AV78 RECOGNIZED BY THE MONOCLONAL HUMAN ANTIBODY 81AV78.
MX9202642A (es) Anticuerpos monoclonales y antigeno para melanoma humano.
DK1027375T3 (da) Anti-idiotypiske monoklonale antistoffer, anvendelse deraf til aktiv immunterapi af maligne tumorer samt præparater, som indeholder disse antistoffer